Pierce K. H. Chow

26.6k total citations · 2 hit papers
384 papers, 14.4k citations indexed

About

Pierce K. H. Chow is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Pierce K. H. Chow has authored 384 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Hepatology, 128 papers in Surgery and 117 papers in Oncology. Recurrent topics in Pierce K. H. Chow's work include Hepatocellular Carcinoma Treatment and Prognosis (135 papers), Pancreatic and Hepatic Oncology Research (67 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (47 papers). Pierce K. H. Chow is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (135 papers), Pancreatic and Hepatic Oncology Research (67 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (47 papers). Pierce K. H. Chow collaborates with scholars based in Singapore, Hong Kong and United States. Pierce K. H. Chow's co-authors include London Lucien Ooi, Brian K. P. Goh, Wai‐Keong Wong, Peng Chung Cheow, Alexander Yaw Fui Chung, Hung Huynh, Yu‐Meng Tan, Khee Chee Soo, Alexander Chung and Hock Soo Ong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Pierce K. H. Chow

377 papers receiving 14.1k citations

Hit Papers

Microvascular Invasion Is a Better Predictor of Tumor Rec... 2011 2026 2016 2021 2011 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria
    2011 423 citations Pierce K. H. Chow, Peng Chung Cheow et al. profile →
  2. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
    2023 79 citations Pierce K. H. Chow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierce K. H. Chow Singapore 65 4.5k 3.9k 3.8k 3.3k 2.7k 384 14.4k
Hys Ngan Hong Kong 68 2.7k 0.6× 4.1k 1.1× 3.8k 1.0× 6.9k 2.1× 2.1k 0.8× 521 21.5k
Osamu Ishikawa Japan 65 1.5k 0.3× 6.2k 1.6× 5.2k 1.4× 3.8k 1.2× 3.8k 1.4× 751 17.3k
Jun Li China 50 1.8k 0.4× 2.4k 0.6× 4.0k 1.0× 1.9k 0.6× 2.1k 0.8× 465 10.7k
Luigi Terracciano Switzerland 86 4.1k 0.9× 8.7k 2.3× 4.1k 1.1× 9.2k 2.8× 4.3k 1.6× 565 26.2k
Kaichun Wu China 80 1.4k 0.3× 4.1k 1.1× 3.7k 1.0× 11.4k 3.5× 2.6k 1.0× 622 21.3k
Gregory Y. Lauwers United States 88 5.2k 1.2× 11.2k 2.9× 13.6k 3.5× 5.4k 1.7× 7.2k 2.6× 448 28.5k
Gianluigi Giannelli Italy 54 2.2k 0.5× 3.2k 0.8× 894 0.2× 5.0k 1.5× 831 0.3× 366 12.8k
Steven K. Libutti United States 67 683 0.2× 4.7k 1.2× 3.1k 0.8× 4.9k 1.5× 2.2k 0.8× 331 15.2k
Matthias Löhr Sweden 59 827 0.2× 6.2k 1.6× 6.4k 1.7× 3.3k 1.0× 1.7k 0.6× 409 14.0k
Christiane J. Bruns Germany 63 814 0.2× 8.1k 2.1× 3.8k 1.0× 6.3k 1.9× 3.5k 1.3× 489 16.3k

Countries citing papers authored by Pierce K. H. Chow

Since Specialization
Citations

This map shows the geographic impact of Pierce K. H. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierce K. H. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierce K. H. Chow more than expected).

Fields of papers citing papers by Pierce K. H. Chow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierce K. H. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierce K. H. Chow. The network helps show where Pierce K. H. Chow may publish in the future.

Co-authorship network of co-authors of Pierce K. H. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Pierce K. H. Chow. A scholar is included among the top collaborators of Pierce K. H. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierce K. H. Chow. Pierce K. H. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chan, Siew Wee, Fei Liu, Jun Liu, et al.. (2024). Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges. Cancers. 16(8). 1582–1582. 20 indexed citations
3.
4.
Wee, Ian, Brian K. P. Goh, Chung Yip Chan, et al.. (2023). Extending surgical resection for hepatocellular carcinoma beyond Barcelona Clinic for Liver Cancer (BCLC) stage A: A novel application of the modified BCLC staging system.. Journal of Clinical Oncology. 41(4_suppl). 503–503. 2 indexed citations
5.
Wong, Ting Hway, et al.. (2023). Battling against the great disruption to surgical care in a pandemic: experiences of 11 South and Southeast Asian countries. BMJ Open. 13(4). e060770–e060770. 1 indexed citations
6.
Shuen, Timothy Wai Ho, Marianna Alunni‐Fabbroni, Peter Malfertheiner, et al.. (2022). Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial. Clinical Cancer Research. 28(17). 3890–3901. 26 indexed citations
7.
Zeng, Zeng, Ziyuan Zhao, Yangfan Li, et al.. (2022). CoIn: Correlation Induced Clustering for Cognition of High Dimensional Bioinformatics Data. IEEE Journal of Biomedical and Health Informatics. 27(2). 598–607. 6 indexed citations
8.
Syn, Nicholas, Ye Xin Koh, Jin‐Yao Teo, et al.. (2020). Impact of First Assistant Surgeon Experience on the Perioperative Outcomes of Laparoscopic Hepatectomies. Journal of Laparoendoscopic & Advanced Surgical Techniques. 30(4). 423–428. 3 indexed citations
9.
10.
Lonardo, Amedeo, Stefano Ballestri, Pierce K. H. Chow, & Ayako Suzuki. (2020). Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological findings and pathobiological mechanisms. Hepatoma Research. 2020. 14 indexed citations
11.
12.
Li, Fang, Hung Huynh, Xiaoyan Li, et al.. (2015). FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors. Cancer Discovery. 5(4). 438–451. 85 indexed citations
13.
Kao, Yung Hsiang, et al.. (2014). Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization. EJNMMI Research. 4(1). 33–33. 51 indexed citations
14.
Koh, Ye Xin, Aik Yong Chok, Huili Zheng, et al.. (2013). A Systematic Review and Meta-Analysis Comparing Laparoscopic Versus Open Gastric Resections for Gastrointestinal Stromal Tumors of the Stomach. Annals of Surgical Oncology. 20(11). 3549–3560. 103 indexed citations
15.
Shu, Yang, Van Chanh Ngo, Wei Jie Ong, et al.. (2009). AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer. Molecular Cancer Therapeutics. 8(9). 2537–2545. 28 indexed citations
16.
Kee, Irene, Siang Hui Lai, Choon Hua Thng, et al.. (2008). Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model. PLoS ONE. 3(3). e1734–e1734. 23 indexed citations
17.
Goh, Brian K. P., Yu‐Meng Tan, Peng Chung Cheow, et al.. (2005). Cystic neoplasms of the pancreas with mucin-production. European Journal of Surgical Oncology. 31(3). 282–287. 47 indexed citations
18.
Yuen, John Shyi Peng, Pierce K. H. Chow, Alexander Chung, et al.. (2004). Subspecialization and Pancreaticoduodenectomy: Learning Experience from 71 Consecutive Cases. Asian Journal of Surgery. 27(2). 73–79. 5 indexed citations
19.
Zhang, Kai, Kim Ping Wong, & Pierce K. H. Chow. (2003). Conjugation of chlorambucil with GSH by GST purified from human colon adenocarcinoma cells and its inhibition by plant polyphenols. Life Sciences. 72(23). 2629–2640. 21 indexed citations
20.
Chow, Pierce K. H., et al.. (2000). Changes in prostaglandin and nitric oxide levels in the hyperdynamic circulation following liver resection. Journal of Gastroenterology and Hepatology. 15(8). 895–901. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hys Ngan Breakdown of academic impact, for papers by Osamu Ishikawa Breakdown of academic impact, for papers by Jun Li Breakdown of academic impact, for papers by Luigi Terracciano Breakdown of academic impact, for papers by Kaichun Wu Breakdown of academic impact, for papers by Gregory Y. Lauwers Breakdown of academic impact, for papers by Gianluigi Giannelli Breakdown of academic impact, for papers by Steven K. Libutti Breakdown of academic impact, for papers by Matthias Löhr Breakdown of academic impact, for papers by Christiane J. Bruns
Rankless by CCL
2026